View in EDS HTML Full Text PDF Full Text

Targeting the IL-8 axis in high-risk myelodysplastic syndromes: a clinical experience with antibody blockade combined with decitabine/cedazuridine.

Saved in:
Bibliographic Details
Title: Targeting the IL-8 axis in high-risk myelodysplastic syndromes: a clinical experience with antibody blockade combined with decitabine/cedazuridine.
Authors: Mina, Alain1,2 (AUTHOR), Calvo, Katherine R.2,3 (AUTHOR), McKinnon, Katherine4 (AUTHOR), Raman, Ayush T.5 (AUTHOR), Wang, Weixin3 (AUTHOR), Cunningham, Lea1,2 (AUTHOR), Liu, Yi6 (AUTHOR), Alexander, Rebecca1,2 (AUTHOR), Larson, Daniel R.1,2,5 (AUTHOR), Pavletic, Steven1,2 (AUTHOR), McGraw, Kathy L.1,2,5 (AUTHOR) Kathy.McGraw@NIH.gov
Source: Leukemia & Lymphoma. Jul2026, Vol. 67 Issue 8, p1740-1748. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10428194
DOI:10.1080/10428194.2026.2661078